RxDoctor Payments Data

Jesica Campbell

Women's Health · Chesterfield, MONPI 1225587447

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,086 of the $2,356 with a category attached, or 88.5%. It is spread thinly across 20 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations.

$2,356in general payments, 2019–2025

Across 107 payments — averaging $22.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$552
  • AbbVie$236
  • Exact Sciences$233
  • Evofem Biosciences, Inc.$226
  • Organon$207
  • Hologic Sales And Service, LLC$196
  • plus $706 from 14 others

What the payments were for

  • Food & beverage$2,08689%
  • Education$27011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,356 in reported general payments places this provider in the 85th percentile of 208 women's health providers in Missouri.

See all women's health providers in Missouri

Medicare billing

Part B allowed, 2024
$3,733
Medicare patients
56
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ValacyclovirValacyclovir Hcl14$842
ProgesteroneProgesterone, Micronized24$705
Estradiol24$671
Clobetasol Propionate16$242
Fluconazole16$177
Spironolactone13$155

Paid to pharmacies, not to this prescriber.

Other women's health in Chesterfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →